Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 7, 2010, Pages 519-526

  Brunetti, P ^a   Muggeo, M ^b   Cattin, L ^c   Arcangeli, A ^d   Pozzilli, P ^e   Provenzano, V ^f   Francesconi, A ^g   Calatola, P ^h   Santeusanio, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d AS Diabetes and Metabolic Diseases   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f Department of Internal Medicine   (Italy)

^g SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^h Diabetology Center   (Italy)

Author keywords

Hypoglycemia; Insulin glargine; Type 1 diabetes

Indexed keywords

EID: 77955571410     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.05.007     Document Type: Article

References (14)

1. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med 1991, 90:450-459.
2. Gerich J., Becker R.H., Zhu R., Bolli G.B. Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine. Diabetes Technol Ther 2006, 8:237-243.
3. Lepore M., Pampanelli S., Fanelli C., Porcellati F., Bartocci L., Di Vincenzo A., et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000, 49:2142-2148.
4. Ashwell S.G., Amiel S.A., Bilous R.W., Dashora U., Heller S.R., Hepburn D.A., et al. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabet Med 2006, 23:285-292.
5. Chatterjee S., Jarvis-Kay J., Rengarajan T., Lawrence I.G., McNally P.G., Davies M.J. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes - the glargine and aspart study (GLASS) a randomised cross-over study. Diabetes Res Clin Pract 2007, 77:215-222.
6. Porcellati F., Rossetti P., Pampanelli S., Fanelli C.G., Torlone E., Scionti L., et al. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med 2004, 21:1213-1220.
7. Raskin P., Klaff L., Bergenstal R., Halle J.P., Donley D., Mecca T.A. 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 2000, 23:1666-1671.
8. Mannucci E., Ricci V., Bardini G., Rotella C.M. Well-being enquiry for diabetics: a new measure of diabetes-related quality of life. Diab Nutr Metab 1996, 9:89-102.
9. Annuzzi G., Del Prato S., Arcari R., Bellomo Damato A., Benzi L., Bruttomesso D., et al. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. Nutr Metab Cardiovasc Dis 2001, 11:168-175.
10. Holleman F., Schmitt H., Rottiers R., Rees A., Symanowski S., Anderson J.H. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabetes Care 1997, 20:1827-1832.
11. Lalli C., Ciofetta M., Del Sindaco P., Torlone E., Pampanelli S., Compagnucci P., et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999, 22:468-477.
12. Gale E.A. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group. Diabet Med 2000, 17:209-214.
13. Brownlee M., Hirsch I.B. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006, 295:1707-1708.
14. Garg S.K., Ellis S.L., Ulrich H. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes. Expert Opin Pharmacother 2005, 6:643-651.